Stock listing
NASDAQ:LNSR LENSAR, Inc. Stock
Home listing (NASDAQ) of LENSAR, Inc.
Follow LENSAR, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:LNSR
$4.46 USD -0.39 (-8.0%)
Close on Nov 20, 2026
- Day range
- $4.41 – $4.68 USDNov 20, 2026
- Volume
- 55,030 sharesNov 20, 2026
- Market cap
- $54.83M USDAt the close on Nov 20, 2026 · price × 12.29M shares outstanding
- 52-week range
- $4.30 – $12.94 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $478,133 USDMedian day 60,478 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:LNSR · Home | $4.46 USD | -0.39 (-8.0%) | 55,030 | $4.55 | $4.675 | $4.41 | $4.85 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:LNSR · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $4.46 | -0.39 | -8.0% | $4.55 | $4.675 | $4.41 | 55,030 | |
| $4.85 | -0.06 | -1.2% | $4.92 | $5.11 | $4.84 | 58,089 | |
| $4.91 | -0.38 | -7.2% | $5.27 | $5.40 | $4.89 | 111,963 | |
| $5.29 | +0.29 | +5.8% | $5.06 | $5.405 | $5.06 | 78,279 | |
| $5.00 | +0.30 | +6.4% | $4.75 | $5.08 | $4.68 | 46,886 | |
| $4.70 | +0.12 | +2.6% | $4.59 | $4.87 | $4.41 | 116,999 | |
| $4.58 | -0.04 | -0.9% | $4.82 | $5.003 | $4.30 | 147,163 | |
| $4.62 | -0.84 | -15.4% | $5.00 | $5.35 | $4.62 | 233,252 | |
| $5.46 | +0.01 | +0.2% | $5.51 | $5.76 | $5.32 | 76,945 | |
| $5.45 | -0.05 | -0.9% | $5.50 | $5.50 | $5.335 | 79,082 | |
| $5.50 | -0.34 | -5.8% | $5.915 | $5.945 | $5.46 | 38,135 | |
| $5.84 | +0.27 | +4.8% | $5.59 | $5.94 | $5.58 | 78,355 | |
| $5.57 | -0.10 | -1.8% | $5.70 | $5.70 | $5.485 | 101,817 | |
| $5.67 | -0.17 | -2.9% | $5.84 | $5.86 | $5.60 | 70,188 | |
| $5.84 | -0.13 | -2.2% | $6.00 | $6.03 | $5.76 | 28,836 | |
| $5.97 | +0.05 | +0.8% | $5.94 | $6.05 | $5.905 | 11,813 | |
| $5.92 | -0.02 | -0.3% | $5.96 | $5.97 | $5.82 | 13,863 | |
| $5.94 | -0.02 | -0.3% | $5.93 | $5.97 | $5.845 | 21,543 | |
| $5.96 | -0.11 | -1.8% | $6.03 | $6.10 | $5.95 | 14,658 | |
| $6.07 | +0.05 | +0.8% | $5.98 | $6.105 | $5.93 | 28,418 | |
| $6.02 | +0.33 | +5.8% | $5.69 | $6.09 | $5.69 | 163,211 | |
| $5.69 | -0.12 | -2.1% | $5.77 | $5.83 | $5.68 | 29,444 | |
| $5.81 | +0.06 | +1.0% | $5.75 | $5.90 | $5.74 | 51,949 | |
| $5.75 | -0.05 | -0.9% | $5.80 | $5.90 | $5.74 | 60,342 | |
| $5.80 | -0.23 | -3.8% | $6.03 | $6.16 | $5.80 | 76,640 | |
| $6.03 | -0.08 | -1.3% | $6.11 | $6.24 | $6.025 | 41,418 | |
| $6.11 | -0.16 | -2.6% | $6.22 | $6.32 | $6.075 | 44,703 | |
| $6.27 | +0.05 | +0.8% | $6.21 | $6.32 | $6.205 | 23,868 | |
| $6.22 | -0.15 | -2.4% | $6.38 | $6.38 | $6.17 | 43,753 | |
| $6.37 | -0.08 | -1.2% | $6.43 | $6.543 | $6.37 | 15,331 | |
| $6.45 | -0.06 | -0.9% | $6.50 | $6.51 | $6.37 | 24,825 | |
| $6.51 | -0.19 | -2.8% | $6.65 | $6.665 | $6.50 | 32,269 | |
| $6.70 | +0.03 | +0.4% | $6.66 | $6.80 | $6.58 | 33,926 | |
| $6.67 | -0.08 | -1.2% | $6.73 | $6.851 | $6.67 | 51,531 | |
| $6.75 | +0.18 | +2.7% | $6.57 | $6.869 | $6.55 | 69,842 | |
| $6.57 | -0.02 | -0.3% | $6.58 | $6.80 | $6.50 | 40,939 | |
| $6.59 | -0.31 | -4.5% | $6.95 | $6.95 | $6.59 | 35,703 | |
| $6.90 | +0.02 | +0.3% | $6.85 | $6.95 | $6.78 | 25,847 | |
| $6.88 | -0.04 | -0.6% | $6.92 | $6.97 | $6.79 | 34,769 | |
| $6.92 | -0.155 | -2.2% | $7.06 | $7.15 | $6.92 | 22,797 | |
| $7.075 | -0.075 | -1.0% | $7.15 | $7.17 | $6.98 | 17,632 | |
| $7.15 | -0.10 | -1.4% | $7.26 | $7.26 | $6.975 | 28,275 | |
| $7.25 | +0.04 | +0.6% | $7.24 | $7.30 | $7.15 | 29,192 | |
| $7.21 | +0.14 | +2.0% | $7.06 | $7.25 | $6.99 | 70,452 | |
| $7.07 | -0.02 | -0.3% | $7.00 | $7.23 | $6.90 | 124,412 | |
| $7.09 | +0.01 | +0.1% | $7.19 | $7.19 | $6.90 | 58,836 | |
| $7.08 | -0.56 | -7.3% | $7.50 | $7.77 | $7.08 | 101,300 | |
| $7.64 | -0.17 | -2.2% | $7.83 | $7.92 | $7.55 | 91,476 | |
| $7.81 | +0.21 | +2.8% | $7.68 | $7.97 | $7.68 | 64,570 | |
| $7.60 | -0.45 | -5.6% | $8.12 | $8.18 | $7.60 | 82,336 | |
| $8.05 | -0.26 | -3.1% | $8.435 | $8.435 | $8.05 | 70,628 | |
| $8.31 | -0.29 | -3.4% | $8.55 | $8.60 | $8.25 | 68,925 | |
| $8.60 | +0.02 | +0.2% | $8.58 | $8.73 | $8.50 | 108,627 | |
| $8.58 | +0.33 | +4.0% | $8.26 | $8.725 | $8.26 | 113,273 | |
| $8.25 | -0.25 | -2.9% | $8.50 | $8.54 | $8.21 | 117,521 | |
| $8.50 | +0.04 | +0.5% | $8.52 | $8.68 | $8.42 | 37,611 | |
| $8.46 | +0.07 | +0.8% | $8.44 | $8.56 | $8.40 | 60,478 | |
| $8.39 | +0.09 | +1.1% | $8.32 | $8.535 | $8.26 | 82,491 | |
| $8.30 | -0.16 | -1.9% | $8.52 | $8.52 | $8.23 | 142,330 | |
| $8.46 | -0.19 | -2.2% | $8.605 | $8.685 | $8.40 | 97,400 | |
| $8.65 | -0.29 | -3.2% | $8.94 | $8.94 | $8.54 | 71,518 | |
| $8.94 | -0.29 | -3.1% | $9.17 | $9.25 | $8.85 | 92,488 | |
| $9.23 | +0.55 | +6.3% | $8.70 | $9.25 | $8.54 | 172,025 | |
| $8.68 | +0.24 | +2.8% | $8.51 | $8.70 | $8.42 | 167,315 | |
| $8.44 | -0.28 | -3.2% | $8.71 | $8.72 | $8.25 | 137,533 |
- Ticker
- NASDAQ:LNSR
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 10, 2026
LENSAR® Reports Third Quarter 2026 Financial Results and Provides Business Update
Latest earnings call · Nov 10, 2026
LENSAR (NASDAQ:LNSR) Q3 2026 Earnings Call
Replay and transcript
Latest deck · August 2026
Investor Presentation (August 2026)
Investor deck · 18 slides
Latest news
LENSAR® Reports Third Quarter 2026 Financial Results and Provides Business Update
Nov 10, 2026
Closed $4.62 (-15.4%) on Nov 10, 2026
LENSAR® to Report Third Quarter 2026 Results on November 10th, 2026
Nov 3, 2026
Closed $5.57 (-1.8%) on Nov 3, 2026
LENSAR® Reports Second Quarter 2026 Results and Provides Business Update
Aug 13, 2026
Closed $8.27 (+31.5%) on Aug 13, 2026
LENSAR® Reports First Quarter 2026 Results and Provides Business Update
May 8, 2026
Closed $5.64 (+7.8%) on May 8, 2026
LENSAR® to Report First Quarter 2026 Results on May 8, 2026
Apr 30, 2026
Closed $5.23 (-3.0%) on Apr 30, 2026
LENSAR® Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update
Mar 31, 2026
Closed $5.96 (+1.5%) on Mar 31, 2026
LENSAR® Announces Termination of Merger Agreement with Alcon Research, LLC
Mar 16, 2026
Closed $6.89 (-32.8%) on Mar 17, 2026
Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement
Mar 16, 2026
Closed $10.26 (+4.2%) on Mar 16, 2026
LENSAR® Provides Update on Pending Acquisition by Alcon
Feb 25, 2026
Closed $12.14 (+1.6%) on Feb 25, 2026
LENSAR, Inc. on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 9 in the last 12 months · 71 in all · newest Nov 10, 2026 · oldest 2020
- Calls
- 19 calls with a replay · 19 with a transcript · latest Nov 10, 2026
- Decks
- 2 decks · latest August 2026
Where LENSAR, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:LNSR · Home listing · This page | NASDAQ | United States | USD |
| BOATS:LNSR | BOATS | United States | USD |
Valuation
P/E 1.6× against a median of 12.1×: the lowest of 8 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $44.40M USD
- P/E
- 1.6×
- EV/sales
- 0.7×
- EV/EBITDA
- 18.0×
- Price/book
- 5.0×
- Gross margin
- 52.0%
- Operating margin
- −3.3%
- Net margin
- 56.1%
- Debt to equity
- 0.2×
- Beta vs S&P 500
- 0.76
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| LENSAR, Inc. · NASDAQ:LNSR | US$54.83M | US$44.40M | 1.6× | 0.7× | 18.0× | 5.0× | 56.1% | 0.2× | 0.76 |
| Vincent Medical Holdings Limited · HKEX:1612 | US$57.26M | US$62.46M | 4.3× | 0.5× | 2.9× | 0.6× | 11.2% | 0.3× | n/a |
| REMED Co., Ltd. · KRX:302550 | US$57.14M | US$51.29M | 37.5× | 2.5× | 20.4× | 2.0× | 7.6% | 0.1× | n/a |
| OK Biotech Co., Ltd. · TWSE:4155 | US$55.10M | US$75.16M | 7.5× | 1.6× | 7.9× | 0.7× | 15.8% | 0.4× | n/a |
| Enzymatica AB · OMXSTO:ENZY | US$55.08M | US$55.77M | n/a | 11.1× | n/a | 6.0× | −80.5% | 0.1× | n/a |
| P&S Robotics Co., Ltd. · KRX:460940 | US$54.38M | US$33.62M | 26.6× | 5.9× | 36.6× | 1.7× | 36.0% | 0.0× | n/a |
| Creo Medical Group PLC · LSE:CREO | US$54.06M | US$49.48M | 7.8× | 6.3× | n/a | 0.9× | 88.3% | 0.1× | n/a |
| Crystalvue Medical Co Ltd · TPEX:6527 | US$53.82M | US$52.19M | 12.1× | 1.8× | 8.7× | 1.7× | 15.5% | 0.0× | n/a |
| 3D Global Biotech Inc. · TPEX:6808 | US$53.26M | US$38.17M | 26.4× | 6.1× | 17.5× | 2.4× | 32.2% | 0.0× | n/a |
| Outset Medical, Inc. · NASDAQ:OM | US$53.03M | US$14.77M | n/a | 0.1× | n/a | 0.6× | −58.3% | 1.2× | 1.74 |
| NeurAxis, Inc. · AMEX:NRXS | US$52.99M | US$48.80M | n/a | 7.5× | n/a | 14.6× | −185.2% | 0.1× | 1.77 |
| Median of the others | US$54.22M | US$50.38M | 12.1× | 4.2× | 13.1× | 1.7× | 13.3% | 0.1× | 1.76 |
Forecasts
3 strong buy · Analysts' consensus from EODHD, read Nov 12, 2026. Not 6ix's view and not investment advice.
- Price target
- 11.33 USD · Analysts' mean
- EPS, year to Dec 2026
- -0.050 · 1 analyst
- Revenue, year to Dec 2026
- 60.9M · 3 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Nicholas T. Curtis | Chief Executive Officer |
| Gregory Parkhurst | Founder |
| Mark Packer | Chief Medical Officer |
| Mitchell A Jackson | Founder |
| Robert J. Weinstock | Director of Cataract and Refractive Surgery |
Board
| Director | Role |
|---|---|
| Carlos Buznego | Chairman of the Board |
| William J. Link | Chairman of the Board |
| Aimee S. Weisner | Director |
| Elizabeth G. O’Farrell | Director |
| Gary M. Winer | Director |
| Nicholas T. Curtis | Chief Executive Officer |
| Richard L. Lindstrom | Director |
| Thomas B. Ellis | Director |
| Todd B. Hammer | Director |
Events
Calls
| Call | When | Status |
|---|---|---|
| LENSAR (NASDAQ:LNSR) Q3 2026 Earnings Call | Tue, Nov 10, 2026 · 8:30 AM ET | Replay |
| LENSAR (NASDAQ:LNSR) Q2 2026 Earnings Call | Thu, Aug 13, 2026 · 8:30 AM ET | Replay |
| LENSAR (NASDAQ:LNSR) Q1 2026 Earnings Call | Fri, May 08, 2026 · 8:30 AM ET | Replay |
| LENSAR (NASDAQ:LNSR) Q4 2025 Earnings Call | Tue, Mar 31, 2026 · 8:30 AM ET | Replay |
| LENSAR (NASDAQ:LNSR) Q4 2024 Earnings Call | Thu, Feb 27, 2025 · 8:30 AM ET | Replay |
| LENSAR (NASDAQ:LNSR) Q3 2024 Earnings Call | Thu, Nov 07, 2024 · 8:30 AM ET | Replay |
| LENSAR (NASDAQ:LNSR) Q1 2024 Earnings Call | Thu, May 09, 2024 · 8:30 AM ET | Replay |
| LENSAR (NASDAQ:LNSR) Q4 2023 Earnings Call | Mon, Mar 04, 2024 · 8:30 AM ET | Replay |
| LENSAR (NASDAQ:LNSR) Q3 2023 Earnings Call | Thu, Nov 09, 2023 · 8:30 AM ET | Replay |
| LENSAR (NASDAQ:LNSR) Q2 2023 Earnings Call | Wed, Aug 09, 2023 · 8:30 AM ET | Replay |
All 19 calls
| Call | When | Status |
|---|---|---|
| LENSAR (NASDAQ:LNSR) Q1 2023 Earnings Call | Mon, May 15, 2023 · 8:30 AM ET | Replay |
| LENSAR (NASDAQ:LNSR) Q4 2022 Earnings Call | Thu, Mar 16, 2023 · 8:30 AM ET | Replay |
| LENSAR (NASDAQ:LNSR) Q3 2022 Earnings Call | Wed, Nov 09, 2022 · 8:30 AM ET | Replay |
| LENSAR (NASDAQ:LNSR) Q2 2022 Earnings Call | Mon, Aug 08, 2022 · 8:30 AM ET | Replay |
| LENSAR (NASDAQ:LNSR) Q1 2022 Earnings Call | Mon, May 09, 2022 · 8:30 AM ET | Replay |
| LENSAR (NASDAQ:LNSR) Q4 2021 Earnings Call | Thu, Mar 03, 2022 · 8:30 AM ET | Replay |
| LENSAR (NASDAQ:LNSR) Q3 2021 Earnings Call | Mon, Nov 08, 2021 · 8:30 AM ET | Replay |
| LENSAR (NASDAQ:LNSR) Q2 2021 Earnings Call | Thu, Aug 05, 2021 · 8:30 AM ET | Replay |
| LENSAR (NASDAQ:LNSR) Q1 2021 Earnings Call | Wed, May 05, 2021 · 8:30 AM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 10, 2026 · Before open | −15.4% |
| Q2 2026 | Aug 13, 2026 · Before open | +31.5% |
| Q1 2026 | May 8, 2026 · Before open | +7.8% |
| Q3 2025 | Nov 6, 2025 · Before open | −8.6% |
| Q2 2025 | Aug 7, 2025 · Before open | −1.5% |
| Q1 2025 | May 8, 2025 · Before open | −0.1% |
| Q4 2024 | Mar 3, 2025 · Before open | +3.7% |
| Q3 2024 | Nov 7, 2024 · Before open | +17.2% |
| Q2 2024 | Aug 8, 2024 · Before open | −9.9% |
| Q1 2024 | May 9, 2024 · Before open | +12.7% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q4 2023 | Mar 4, 2024 · Before open | +2.8% |
| Q3 2023 | Nov 9, 2023 · Before open | +12.4% |
| Q2 2023 | Aug 9, 2023 · Before open | +12.7% |
| Q1 2023 | May 15, 2023 · Before open | −9.4% |
| Q4 2022 | Mar 16, 2023 · Before open | +2.2% |
| Q3 2022 | Nov 9, 2022 · Before open | −11.6% |
| Q2 2022 | Aug 8, 2022 · Before open | +0.9% |
| Q1 2022 | May 9, 2022 · Before open | −1.0% |
| Q4 2021 | Mar 3, 2022 · Before open | +6.3% |
| Quarter to Sep 30, 2021 | Nov 8, 2021 · Before open | −0.7% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (August 2026) | Investor deck | 18 slides | August 2026 |
| Q4 2025 Earnings Presentation | Earnings | 18 slides | Mar 31, 2026 |
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 58.4M | 53.5M | 42.2M | 35.4M | 34.5M | 26.4M | 30.5M | 24.4M |
| Cost of revenue | 31.3M | 27.6M | 21.1M | 15.4M | 16.6M | 12.3M | 17.3M | 14.8M |
| Gross profit | 27.1M | 25.9M | 21.1M | 20.0M | 17.8M | 14.1M | 13.2M | 9.61M |
| Research and development | 5.62M | 5.33M | 6.14M | 11.8M | 12.4M | 7.55M | 7.57M | 2.78M |
| Selling, general and administrative | 45.2M | 26.5M | 26.1M | 27.2M | 23.9M | 23.8M | 17.1M | |
| Operating income | -24.6M | -10.7M | -12.2M | -20.2M | -19.7M | -18.5M | -12.7M | -9.32M |
| Depreciation and amortization | 3.58M | 2.96M | 2.42M | 2.26M | 1.52M | 1.31M | 2.64M | 4.59M |
| EBITDA | -21.0M | -7.70M | -9.81M | -17.9M | -18.1M | -17.2M | -10.1M | -4.73M |
| Interest expense | 263.0K | 1.19M | 1.34M | 2.00M | 0 | |||
| Income before tax | -34.3M | -31.4M | -14.4M | -19.9M | -19.6M | -19.8M | -14.7M | -12.6M |
| Income tax | 3.35M | -263.0K | 51.0K | 1.41M | 2.06M | 20.0K | ||
| Net income | -34.3M | -31.4M | -14.4M | -19.9M | -19.6M | -19.8M | -14.7M | -12.6M |
| Earnings per share, basic | -2.87 | -2.73 | -1.31 | -1.96 | -2.09 | -4.28 | -13.70 | -11.77 |
| Earnings per share, diluted | -2.87 | -2.73 | -1.31 | -1.96 | -2.09 | -4.28 | -13.70 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 13.0M | 16.3M | 20.6M | 14.7M | 31.6M | 40.6M | 4.62M | 3.34M |
| Short-term investments | 5.00M | 6.19M | 3.44M | 0 | ||||
| Receivables | 6.38M | 6.08M | 4.00M | 6.04M | 4.64M | 2.01M | 3.38M | 3.30M |
| Inventory | 21.5M | 11.4M | 15.7M | 11.7M | 6.49M | 13.5M | 8.06M | 4.06M |
| Current assets | 46.8M | 42.0M | 46.4M | 33.7M | 44.8M | 58.4M | 17.2M | 11.7M |
| Property, plant and equipment | 505.0K | 664.0K | 679.0K | 563.0K | 756.0K | 832.0K | 720.0K | 3.62M |
| Total assets | 71.4M | 66.3M | 69.6M | 55.8M | 66.5M | 79.1M | 34.5M | 28.9M |
| Accounts payable | 19.0M | 6.00M | 4.01M | 5.42M | 2.69M | 2.48M | 1.58M | 1.41M |
| Current liabilities | 40.6M | 15.0M | 11.6M | 11.4M | 8.71M | 8.47M | 7.83M | 7.66M |
| Long-term debt | 20.2M | |||||||
| Total debt | 2.73M | 2.61M | 2.31M | 2.80M | 3.31M | 3.81M | 20.5M | 41.2M |
| Total liabilities | 83.7M | 47.7M | 22.4M | 13.9M | 11.6M | 11.9M | 65.1M | 49.4M |
| Shareholders' equity | -26.0M | 4.86M | 33.4M | 42.0M | 54.9M | 67.2M | -30.6M | -20.5M |
| Shares outstanding | 12.0M | 11.7M | 11.3M | 11.1M | 11.0M | 10.9M | 1.07M | 1.07M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | -14.8M | -2.27M | -9.66M | -14.9M | -8.97M | -13.8M | -12.6M | -1.89M |
| Capital spending | -83.0K | -156.0K | -236.0K | -115.0K | -354.0K | -366.0K | -389.0K | -3.25M |
| Free cash flow | -14.9M | -2.43M | -9.89M | -15.0M | -9.32M | -14.2M | -13.0M | -5.13M |
| Cash from investing | 1.28M | -2.16M | -4.16M | -115.0K | -354.0K | -326.0K | -2.09M | -3.89M |
| Cash from financing | 10.3M | 78.0K | 19.8M | -1.99M | 361.0K | 50.0M | 15.9M | 6.96M |
| Dividends paid | 0 | -1.86M | -31.0K | -198.0K | ||||
| Share buybacks | 590.0K | 306.0K | 327.0K | 408.0K | 361.0K | -12.4M | -13.2M | |
| Change in cash | -3.29M | -4.36M | 5.95M | -17.0M | -8.96M | 35.9M | 1.27M | 1.18M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 19, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 18, 2026 | Other filings | SEC |
| 144 · Notice of proposed sale | Nov 17, 2026 | Other filings | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 16, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 13, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 10, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 10, 2026 | Results | SEC |
| 10-Q · Quarterly report | Aug 13, 2026 | Quarterly report | SEC |
| 8-K · Current report | Aug 13, 2026 | Results | SEC |
| 8-K · Current report | Aug 10, 2026 | Meeting outcome | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| SCHEDULE 13G/A · Big-stake notice, amended | Jul 29, 2026 | Big-stake notice | SEC |
| DEFA14A · Additional proxy material | Jun 23, 2026 | Meeting notice | SEC |
| ARS · Annual report to shareholders | Jun 23, 2026 | Annual report | SEC |
| DEF 14A · Proxy statement | Jun 23, 2026 | Meeting notice | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jun 5, 2026 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Jun 2, 2026 | Offer document | SEC |
| 8-K · Current report | May 29, 2026 | Management or board change | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 14, 2026 | Big-stake notice | SEC |
| 144 · Notice of proposed sale | May 12, 2026 | Other filings | SEC |
| 4 · Change in ownership | May 8, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 8, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 8, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 8, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | May 8, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 8, 2026 | Results | SEC |
| 10-K/A · Annual report, amended | Apr 30, 2026 | Annual report | SEC |
| 8-K · Current report | Apr 15, 2026 | Management or board change | SEC |
| 10-K · Annual report | Mar 31, 2026 | Annual report | SEC |
| 8-K · Current report | Mar 31, 2026 | Results | SEC |
| 4 · Change in ownership | Mar 19, 2026 | Insider trade | SEC |
| 8-K · Current report | Mar 17, 2026 | Material contract | SEC |
| 8-K/A · Current report, amended | Mar 13, 2026 | Current report | SEC |
| 8-K · Current report | Mar 12, 2026 | Current report | SEC |
| 8-K · Current report | Feb 25, 2026 | Current report | SEC |
| 4 · Change in ownership | Feb 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 20, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 13, 2026 | Insider trade | SEC |
| 8-K · Current report | Dec 19, 2025 | Meeting outcome | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 13, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 6, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 6, 2025 | Results | SEC |
| ARS · Annual report to shareholders | Nov 5, 2025 | Annual report | SEC |
| DEFA14A · Additional proxy material | Nov 5, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Nov 5, 2025 | Meeting notice | SEC |
| 8-K · Current report | Oct 21, 2025 | Current report | SEC |
| SCHEDULE 13G · Big-stake notice | Oct 17, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Aug 7, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 7, 2025 | Results | SEC |
| 8-K · Current report | Jul 2, 2025 | Meeting outcome | SEC |
| DEFA14A · Additional proxy material | Jun 25, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | May 28, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 28, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 28, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 28, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 28, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 28, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 28, 2025 | Insider trade | SEC |
| DEFA14A · Additional proxy material | May 22, 2025 | Meeting notice | SEC |
| 8-K · Current report | May 22, 2025 | Current report | SEC |
| DEFM14A | May 19, 2025 | Meeting notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 15, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 13, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | May 8, 2025 | Quarterly report | SEC |
| 8-K/A · Current report, amended | May 8, 2025 | Current report | SEC |
| 8-K · Current report | May 8, 2025 | Results | SEC |
| PREM14A | May 7, 2025 | Other filings | SEC |
| 10-K/A · Annual report, amended | Apr 30, 2025 | Annual report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Apr 15, 2025 | Big-stake notice | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Mar 25, 2025 | Big-stake notice | SEC |
| DFAN14A | Mar 24, 2025 | Other filings | SEC |
| DEFA14A · Additional proxy material | Mar 24, 2025 | Meeting notice | SEC |
| DEFA14A · Additional proxy material | Mar 24, 2025 | Meeting notice | SEC |
| 8-K · Current report | Mar 24, 2025 | Material contract | SEC |
| S-8 · Registration statement for employee plans | Feb 28, 2025 | Offer document | SEC |
| 10-K · Annual report | Feb 27, 2025 | Annual report | SEC |
| 8-K · Current report | Feb 27, 2025 | Results | SEC |
| 4 · Change in ownership | Feb 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 20, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 20, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 14, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Feb 6, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 6, 2025 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 14, 2024 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 7, 2024 | Quarterly report | SEC |
| 8-K · Current report | Nov 7, 2024 | Results | SEC |
| 4 · Change in ownership | Sep 6, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 29, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 23, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 20, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 14, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 12, 2024 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 8, 2024 | Quarterly report | SEC |
| 8-K · Current report | Aug 8, 2024 | Results | SEC |
| 8-K · Current report | May 13, 2024 | Meeting outcome | SEC |
| 4 · Change in ownership | May 9, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 9, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 9, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 9, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 9, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 9, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 9, 2024 | Insider trade | SEC |
| 10-Q · Quarterly report | May 9, 2024 | Quarterly report | SEC |
| 8-K · Current report | May 9, 2024 | Results | SEC |
| 4 · Change in ownership | May 8, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 8, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 8, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 8, 2024 | Insider trade | SEC |
| 8-K · Current report | May 8, 2024 | Management or board change | SEC |
| ARS · Annual report to shareholders | Mar 25, 2024 | Annual report | SEC |
| DEFA14A · Additional proxy material | Mar 25, 2024 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Mar 25, 2024 | Meeting notice | SEC |
| S-8 · Registration statement for employee plans | Mar 5, 2024 | Offer document | SEC |
| 10-K · Annual report | Mar 4, 2024 | Annual report | SEC |
| 8-K · Current report | Mar 4, 2024 | Results | SEC |
| 8-K · Current report | Feb 26, 2024 | Management or board change | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 14, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 13, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 9, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Feb 6, 2024 | Management or board change | SEC |
| SC 13G/A · Big-stake notice, amended | Dec 11, 2023 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 27, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Nov 17, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Nov 14, 2023 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 9, 2023 | Quarterly report | SEC |
| 8-K · Current report | Nov 9, 2023 | Results | SEC |
| 8-K · Current report | Oct 13, 2023 | Management or board change | SEC |
| 4 · Change in ownership | Aug 14, 2023 | Insider trade | SEC |
| 424B3 · Prospectus | Aug 11, 2023 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Aug 11, 2023 | Other filings | SEC |
| 10-Q · Quarterly report | Aug 9, 2023 | Quarterly report | SEC |
| 8-K · Current report | Aug 9, 2023 | Results | SEC |
| CORRESP · Letter to the SEC | Aug 8, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Aug 4, 2023 | Other filings | SEC |
| S-3/A · Registration statement, amended | Aug 4, 2023 | Offer document | SEC |
| 8-K · Current report | Aug 4, 2023 | Meeting outcome | SEC |
| PX14A6G | Jul 27, 2023 | Other filings | SEC |
| PX14A6G | Jul 14, 2023 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jul 13, 2023 | Other filings | SEC |
| S-3 · Registration statement | Jun 26, 2023 | Offer document | SEC |
| DEFA14A · Additional proxy material | Jun 20, 2023 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Jun 20, 2023 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Jun 8, 2023 | Meeting notice | SEC |
| 4 · Change in ownership | Jun 6, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jun 6, 2023 | Insider trade | SEC |
| 3 · Initial statement of ownership | Jun 6, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 30, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 30, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 30, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 30, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 30, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 30, 2023 | Insider trade | SEC |
| 8-K · Current report | May 30, 2023 | Meeting outcome | SEC |
| D | May 25, 2023 | Other filings | SEC |
| 4 · Change in ownership | May 23, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 19, 2023 | Insider trade | SEC |
| SC 13D · Big-stake notice | May 19, 2023 | Big-stake notice | SEC |
| 8-K · Current report | May 18, 2023 | Material contract | SEC |
| 10-Q · Quarterly report | May 15, 2023 | Quarterly report | SEC |
| 8-K · Current report | May 15, 2023 | Material contract | SEC |
| 8-K · Current report | May 15, 2023 | Results | SEC |
| ARS · Annual report to shareholders | Apr 20, 2023 | Annual report | SEC |
| DEFA14A · Additional proxy material | Apr 12, 2023 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Apr 12, 2023 | Meeting notice | SEC |
| S-8 · Registration statement for employee plans | Mar 20, 2023 | Offer document | SEC |
| 10-K · Annual report | Mar 16, 2023 | Annual report | SEC |
| 8-K · Current report | Mar 16, 2023 | Results | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 14, 2023 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 14, 2023 | Big-stake notice | SEC |
| 8-K · Current report | Feb 14, 2023 | Results | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 13, 2023 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 10, 2023 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 8, 2023 | Big-stake notice | SEC |
| 4 · Change in ownership | Jan 13, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 13, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 13, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 13, 2023 | Insider trade | SEC |
| 8-K · Current report | Jan 13, 2023 | Management or board change | SEC |
| 4 · Change in ownership | Dec 7, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Nov 23, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Nov 17, 2022 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 9, 2022 | Quarterly report | SEC |
| 8-K · Current report | Nov 9, 2022 | Results | SEC |
| 8-K · Current report | Sep 8, 2022 | Current report | SEC |
| 4 · Change in ownership | Aug 22, 2022 | Insider trade | SEC |
| 8-K · Current report | Aug 16, 2022 | Current report | SEC |
| 424B5 · Prospectus | Aug 9, 2022 | Offer document | SEC |
This page holds 200 of 334 filings. Open Filings
Cap table
Built by 6ix from LENSAR, Inc.’s releases · as of Oct 31, 2026
- Common shares
- 12,294,241
- Fully diluted
- 12,294,241
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 12,294,241 | Oct 31, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Oct 31, 2026 | 12,294,241 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| William J. Link Other companies: RxSight, Inc. (Director · Since at least Jul 29, 2021); Tarsus Pharmaceuticals, Inc. (Director · Since at least Oct 15, 2020); Oyster Point Pharma Inc (Director · Oct 30, 2019 – Jan 5, 2022 · Past); Glaukos Corporation (Director · Jun 24, 2015 – Jun 3, 2021 · Past); Vivani Medical, Inc. (Director · Nov 18, 2014 – Jun 4, 2019 · Past); Flexion Therapeutics Inc (Director · Sep 10, 2014 – Sep 10, 2014 · Past); Inogen, Inc (Director · Feb 12, 2014 – Feb 20, 2014 · Past); Edwards Lifesciences Corporation (Director · May 15, 2013 – May 8, 2020 · Past) | Director · Since at least Sep 17, 2020 |
| Aimee S. Weisner Other companies: Glaukos Corporation (Director · Since at least Jun 24, 2015); STAAR Surgical Company (Director · Jun 16, 2022 – Jun 20, 2024 · Past); Oyster Point Pharma Inc (Director · Oct 30, 2019 – Jan 3, 2023 · Past); Edwards Lifesciences Corporation (CVP, General Counsel · Jan 14, 2011 – May 9, 2012 · Past); Advanced Medical Optics Inc (EVP, Administration & Sec'y · May 24, 2006 – May 29, 2008 · Past) | Director · Since at least Feb 1, 2021 |
| Elizabeth G. O’Farrell Other companies: SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Geron Corporation (Director · Since at least May 10, 2022); Inhibikase Therapeutics, Inc. (Director · Jun 24, 2022 – Jun 24, 2022 · Past) | Director · Since at least May 25, 2022 |
| Richard Lindstrom Other companies: Ocular Therapeutix, Inc. (Director · Since at least Jun 14, 2018); TearLab Corporation (TEAR) (Director · Mar 10, 2020 – Mar 10, 2020 · Past); Harrow, Inc. (Director · Jun 29, 2018 – Sep 30, 2022 · Past) | Director · Since at least Sep 17, 2020 |
| Thomas Ellis Other companies: Creative Realities, Inc. (Director · Since at least Jan 28, 2026); LightPath Technologies, Inc. (Director · Since at least Jun 16, 2025); Guerrilla RF, Inc (Director · Since at least Aug 5, 2024) | Director · Since at least May 18, 2023 |
| Thomas R Staab II Other companies: Tenax Therapeutics, Inc. (Chief Financial Officer · Since at least May 11, 2026); BioCryst Pharmaceuticals, Inc. (Senior Vice President and CFO · Jul 1, 2011 – Feb 21, 2020 · Past); Inspire Pharmaceuticals Inc (EVP, CFO & Treasurer · Jan 19, 2006 – May 13, 2011 · Past) | Chief Financial Officer · Since at least Sep 17, 2020 |
| Daniel Cravens Other companies: STAAR Surgical Company (Investor Relations · Since at least Jan 6, 2026) | Investor Relations · Mar 16, 2026 – Nov 5, 2026 · Past |
| Gary M. Winer Other companies: HCW Biologics Inc. (Director · Oct 26, 2021 – May 16, 2025 · Past) | Director · Since at least Sep 17, 2020 |
| Michael A Rossi Other companies: Harvard Bioscience, Inc. (Chief Financial Officer · Jul 18, 2019 – Dec 29, 2022 · Past) | Interim CFO · Since at least May 29, 2026 |
| Todd B. Hammer Other companies: Guerrilla RF, Inc (Director · Since at least May 15, 2026) | Director · Since at least May 23, 2025 |
All 18 people
| Person | Seat |
|---|---|
| Alan B Connaughton | Chief Operating Officer · Since at least Sep 17, 2020 |
| Carlos Buznego | Chairman of the Board · Since at least Nov 4, 2026 |
| Gregory Parkhurst | Founder · Since at least Nov 4, 2026 |
| Kendra Wong | Principal Accounting Officer · Since at least Jan 11, 2022 |
| Mark Packer | Chief Medical Officer · Since at least Nov 4, 2026 |
| Mitchell A Jackson | Founder · Since at least Nov 4, 2026 |
| Nicholas T. Curtis | Chief Executive Officer · Since at least Sep 17, 2020 |
| Robert J. Weinstock | Director of Cataract and Refractive Surgery · Since at least Nov 4, 2026 |
Log in to ask 6ix AI your own questions about LENSAR, Inc.